A Single-Arm Phase II Study in Japan to Assess the Efficacy and Safety of Aflibercept Administered Every Two Weeks in Combination With FOLFIRI in Patients With Metastatic Colorectal Cancer Who Progressed During or Following an Oxaliplatin-Based Regimen

Name: A Single-Arm Phase II Study in Japan to Assess the Efficacy and Safety of Aflibercept Administered Every Two Weeks in Combination With FOLFIRI in Patients With Metastatic Colorectal Cancer Who Progressed During or Following an Oxaliplatin-Based Regimen
Creator: Vivli
Published: 2025-09-09 14:06:54
License: 暂无描述

DataCite Commons2025-09-09 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00011605/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

Primary Objective:To assess efficacy aflibercept + 5-fluorouracil (5-FU)/levofolinate/irinotecan (FOLFIRI) by objective response rate (ORR).Secondary Objective:To assess the following:* safety profile;* progression free survival (PFS);* overall survival (OS);* pharmacokinetics (PK);* immunogenicity.

提供机构：

Vivli

创建时间：

2025-07-07